Krebs Biochem

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE268B01013
  • NSEID: KREBSBIO
  • BSEID: 524518
INR
57.75
-0.01 (-0.02%)
BSENSE

Aug 12, 03:30 PM

BSE+NSE Vol: 890

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 142337,
    "name": "Krebs Biochem",
    "stock_name": "Krebs Biochem",
    "full_name": "Krebs Biochemicals & Industries Ltd",
    "name_url": "stocks-analysis/krebs-biochem",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "57.75",
    "chg": -0.01,
    "chgp": "-0.02%",
    "dir": -1,
    "prev_price": "57.76",
    "mcapval": "124.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524518,
    "symbol": "KREBSBIO",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE268B01013",
    "curr_date": "Aug 12, 03:30 PM",
    "curr_time": "01:09 AM",
    "last_traded_at": "Aug 12, 03:30 PM IST",
    "bse_nse_vol": "890 ",
    "exc_status": "Active",
    "traded_date": "Aug 12, 2026",
    "traded_date_str": "2026 08 12",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/krebs-biochem-142337-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4145172",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KrebsBiochemica_mojoScore_4145172.png",
        "date": "2026-08-10 10:10:22",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Reports Flat Quarterly Performance Amid Margin Improvements",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-reports-flat-quarterly-performance-amid-margin-improvements-4140808",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/KrebsBiochemica_fintrenddot_4140808.png",
        "date": "2026-08-07 08:00:05",
        "description": "Krebs Biochemicals & Industries Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended June 2026, signalling a pause in its recent downward trend. Despite some operational improvements, the company continues to face liquidity challenges and weak debtor management, which weigh on its overall financial health."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4128505",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KrebsBiochemica_mojoScore_4128505.png",
        "date": "2026-07-30 10:10:29",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 30 July 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4107972",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KrebsBiochemica_mojoScore_4107972.png",
        "date": "2026-07-19 10:10:15",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 19 July 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Locks at Upper Circuit With 9.99% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-upper-circuit-amid-strong-buying-pressure-4095274",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KrebsBiochemica_stocks_hitting_upper_circuit_4095274.png",
        "date": "2026-07-09 12:00:06",
        "description": "At Rs 59.43, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Krebs Biochemicals & Industries Ltd locked at its upper circuit of 9.99% on 9 Jul 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd Locks at Lower Circuit With 6.51% Loss — Sellers Queue, No Buyers in Sight",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/krebs-biochemicals-industries-ltd-hits-lower-circuit-amid-heavy-selling-pressure-4093691",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KrebsBiochemica_stocks_hitting_lower_circuit_4093691.png",
        "date": "2026-07-08 12:00:07",
        "description": "At Rs 54.39, sellers were still queuing — but there were no buyers willing to take the other side. Krebs Biochemicals & Industries Ltd locked at its lower circuit of 6.51% on 7 Jul 2026, with unfilled sell orders and a frozen price, reflecting a pronounced imbalance in supply and demand."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4092227",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/KrebsBiochemica_mojoScore_4092227.png",
        "date": "2026-07-07 10:10:21",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 06 Feb 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 July 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4074020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KrebsBiochemica_mojoScore_4074020.png",
        "date": "2026-06-26 10:10:18",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 Feb 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 26 June 2026, providing investors with the latest insights into its performance and prospects."
      },
      {
        "title": "Krebs Biochemicals & Industries Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/krebs-biochemicals-industries-ltd-is-rated-strong-sell-4054136",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/KrebsBiochemica_mojoScore_4054136.png",
        "date": "2026-06-15 10:10:37",
        "description": "Krebs Biochemicals & Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 06 February 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 15 June 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook."
      }
    ],
    "total": 164,
    "sid": "142337",
    "stock_news_url": "https://www.marketsmojo.com/news/krebs-biochemicals-industries-142337"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "07-Aug-2026",
      "details": "The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026",
      "source": "BSE"
    },
    {
      "caption": "Results",
      "datetime": "06-Aug-2026",
      "details": "Results for the quarter ended 30602026",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Outcome Of BM",
      "datetime": "06-Aug-2026",
      "details": "Outcome of BM",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Krebs Biochemicals & Industries Ltd has announced <strong>21:100</strong> rights issue, ex-date: 31 Jan 19",
          "dt": "2019-01-31",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Newspaper Publication

07-Aug-2026 | Source : BSE

The Company has enclosed herewith copy of newpapers advertiesment of unaudited financial results for the quarter ended 30.06.2026

Results

06-Aug-2026 | Source : BSE

Results for the quarter ended 30602026

Board Meeting Outcome for Outcome Of BM

06-Aug-2026 | Source : BSE

Outcome of BM

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Krebs Biochemicals & Industries Ltd has announced 21:100 rights issue, ex-date: 31 Jan 19